Bone marrow fat changes after gastric bypass versus sleeve in postmenopausal women
Official title: Bone Marrow Fat and Bariatric Surgery-Mediated Bone Loss
Run by University Hospital, Lille · NCT05005039 · Data updated 2026-11-12
This study will test whether bone marrow fat changes differently after gastric bypass (RYGB) versus sleeve gastrectomy (SG) in postmenopausal women with obesity and whether those changes relate to diabetes status and metabolic or hormonal markers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years to 70 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | University Hospital, Lille Academic / other |
| Drugs / interventions | denosumab, radiation |
| Locations | 1 site (Lille) |
| Status | Recruiting |
| Started | April 20, 2022 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | April 20, 2026 |
| Trial ID | NCT05005039 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are postmenopausal women (last menses >12 months) with BMI ≥35 kg/m² who are scheduled for their first RYGB or SG and who do not have major conditions or treatments affecting bone metabolism.
✕Probably not a fit
Patients already on anti-osteoporotic therapy, recent corticosteroid treatment, or with conditions that affect bone metabolism (for example uncontrolled hyperthyroidism, primary hyperparathyroidism, or recent spine/hip radiation) are unlikely to benefit and may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study enrolling postmenopausal women with obesity who are scheduled for first-time RYGB or SG to measure bone marrow fat fraction (BMFF) before and after surgery. Participants will undergo imaging to quantify BMFF and blood tests to profile glycemic control, lipids, adipokines (leptin, adiponectin), calciotropic hormones, and other candidate mediators such as G-CSF. The primary analytic approach compares BMFF changes between surgical types and by diabetic status, and explores correlations between BMFF change and metabolic/hormonal factors. The goal is to identify patterns and potential biological mediators that might explain bariatric surgery–associated bone loss.
Why it matters
Potential benefit: If successful, the findings could help identify mechanisms of bone loss after bariatric surgery and inform strategies to protect bone health in this population.
How similar studies have gone: Prior studies have reported inconsistent results and no single molecular mechanism has been confirmed, so this observational approach is exploratory rather than building on a clearly established success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Postmenopausal women (defined as last menses \>12 months) * Obesity with a BMI ≥ 35 kg/m², * Patients with an indication for bariatric surgery with two surgical techniques, RYGB and SG, but who have never had a bariatric surgery procedure previously, * Patients who have signed the informed consent. Exclusion Criteria: * History of an osteoporotic fracture 2- Current corticosteroid therapy or corticosteroid therapy within the past 3 months, C-onditions or treatments affecting bone metabolism (breast cancer treated with aromatase inhibitors, malabsorption, stomach cancer, primary hyperparathyroidism, uncontrolled hyperthyroidism…), * History of radiation therapy to the lumbar spine or the hip being studied, * Patients on hormone replacement therapy (HRT) or patients already on anti-osteoporotic treatment (bisphosphonates, strontium ranelate, teriparatide, or denosumab) other than calcium and/or vitamin D supplementation, * Chronic kidney disease with a creatinine clearance (CKD-EPI formula) ≤ 30 mL/min, * Weight \> 160 kg, as the bone densitometer table is limited to this weight for the examination, * Patients who have previously undergone bariatric surgery, * Patients with orthopedic implants in both hips or the lumbar spine, * Individuals unable to give personal consent, * Individuals under legal guardianship or conservatorship, * Patients not enrolled in a social security program. * Any contraindication to MRI: (claustrophobia, patients with a pacemaker/defibrillator, cochlear implant, neurostimulator, or orthopedic implants in the hip, pelvis, or lumbar spine, etc.).
Where it's running
-
Hopital Roger Salengro, CHU Lille
Lille, France Recruiting
Study contacts
- Principal investigator: Julien PACCOU, MD,PhD — University Hospital, Lille
- Study coordinator: Julien PACCOU, MD,PhD
- Email: julien.paccou@chru-lille.fr
- Phone: 0320445962
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pediatric Congenital Adrenal Hyperplasia: Long-Term Outcomes and Feelings of Regret
This study looks at adults who had classic CAH from 21-hydroxylase deficiency as children to see if early surgeries and management choices are linked to long‑term satisfaction or regret.
-
Predicting Low Cardiac Output in Children After Heart Surgery Using CO2-Derived Parameters
This study tests whether CO2-derived measures can help identify low cardiac output in children after congenital heart surgery.
-
Switching to Ofatumumab: IgG Levels in People with MS
A real-life study tests whether stopping ocrelizumab and starting ofatumumab changes IgG levels in adults with multiple sclerosis who have been on ocrelizumab for at least 18 months.
-
Identifying biomarkers for CAR-T cell therapy in cancer patients
This study looks at real-world CAR-T therapy in adults with blood cancers to see which biomarkers predict who responds or relapses.
-
Long-term real-world follow-up of adults with cutaneous squamous cell carcinoma needing systemic treatment in France
This study tests how adults with cutaneous squamous cell carcinoma who require systemic therapy are managed in real life, using a national French database across multiple centers.
-
Paravertebral Catheter Analgesia Versus Epidural Analgesia for Totally Minimally Invasive Esophagectomy
This trial tests whether paravertebral catheter analgesia can provide comparable pain control to epidural analgesia for patients undergoing totally minimally invasive esophagectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.